Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 10 of 44 for:    somatostatin analogues | Neuroendocrine Tumors

Randomized Phase III of PRRT Versus Interferon (CASTOR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01860742
Recruitment Status : Withdrawn
First Posted : May 23, 2013
Last Update Posted : April 5, 2016
Sponsor:
Information provided by (Responsible Party):
Jules Bordet Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : October 2016
  Estimated Study Completion Date : October 2016